Assess progression/response of disease to treatment: transverse myelitis now treated with IVIG and IV steroids. There is increased confluent T2 hyperintensity and swelling in the anterior and central portions of the spinal cord extending from the C6 to T6 levels. There is no associated abnormal enhancement or mass lesions. The vertebral column alignment is within normal limits. The vertebral body and disc space heights are preserved. The vertebral bone marrow signal is unremarkable. There is no significant spinal canal stenosis. The paravertebral soft tissues are unremarkable.
Increased confluent T2 hyperintensity and swelling in the anterior and central portions of the spinal cord extending from the C6 to T6 levels.